Literature DB >> 11578086

Anti-SAG1 peptide antibodies inhibit the penetration of Toxoplasma gondii tachyzoites into enterocyte cell lines.

F Velge-Roussel1, I Dimier-Poisson, D Buzoni-Gatel, D Bout.   

Abstract

The initial attachment of Toxoplasma tachyzoites to the target host cell is an important event in the life-cycle of the parasite and a critical stage in infection. Previous studies have shown that polyclonal antibodies directed against the major surface antigen of Toxoplasma gondii (SAG1) inhibit the infection of enterocyte cell lines. Here, we demonstrate that antibodies raised against a central peptide (V41T) of SAG1 and the SAGI protein itself are able to inhibit the infection of various cell lines by the tachyzoites. Antibodies directed against SAG1 peptides were used to define a site on the SAGI antigen that interacts with the host cell. The epitope carried by V41T was identified on the tachyzoite surface by immunofluorescence. The peptide sequence seems to be conserved in all the members of the SAGI Related Sequence family (SRS). Using undifferentiated and differentiated Caco-2 cells, we found that tachyzoites enter preferentially via the basolateral side of the cell. These findings highlight the role of the SRS family members in the mediation of host cell invasion.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11578086     DOI: 10.1017/s0031182001008460

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  8 in total

1.  Toxoplasma gondii-specific immunoglobulin M limits parasite dissemination by preventing host cell invasion.

Authors:  Kevin N Couper; Craig W Roberts; Frank Brombacher; James Alexander; Lawrence L Johnson
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Generation of a neutralizing human monoclonal antibody Fab fragment to surface antigen 1 of Toxoplasma gondii tachyzoites.

Authors:  Yong-Feng Fu; Meng Feng; Kenji Ohnishi; Tamon Kimura; Johbu Itoh; Xun-Jia Cheng; Hiroshi Tachibana
Journal:  Infect Immun       Date:  2010-10-18       Impact factor: 3.441

Review 3.  PLGA Nanoparticles as an Efficient Platform in Protein Vaccines Against Toxoplasma gondii.

Authors:  Mojgan Allahyari
Journal:  Acta Parasitol       Date:  2022-01-11       Impact factor: 1.440

4.  Vaccination with Toxoplasma gondii SAG-1 protein is protective against congenital toxoplasmosis in BALB/c mice but not in CBA/J mice.

Authors:  Valerie Letscher-Bru; Alexander W Pfaff; Ahmed Abou-Bacar; Denis Filisetti; Elisabeth Antoni; Odile Villard; Jean-Paul Klein; Ermanno Candolfi
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

5.  Targeted Delivery of Toxoplasma gondii Antigens to Dendritic Cells Promote Immunogenicity and Protective Efficiency against Toxoplasmosis.

Authors:  Zineb Lakhrif; Alexis Moreau; Bruno Hérault; Anne Di-Tommaso; Matthieu Juste; Nathalie Moiré; Isabelle Dimier-Poisson; Marie-Noëlle Mévélec; Nicolas Aubrey
Journal:  Front Immunol       Date:  2018-02-20       Impact factor: 7.561

6.  Immunogenicity of a Virus-Like-Particle Vaccine Containing Multiple Antigenic Epitopes of Toxoplasma gondii Against Acute and Chronic Toxoplasmosis in Mice.

Authors:  Jingjing Guo; Aihua Zhou; Xiahui Sun; Wenchao Sha; Kang Ai; Ge Pan; Chunxue Zhou; Huaiyu Zhou; Hua Cong; Shenyi He
Journal:  Front Immunol       Date:  2019-03-29       Impact factor: 7.561

7.  SAG2A protein from Toxoplasma gondii interacts with both innate and adaptive immune compartments of infected hosts.

Authors:  Arlindo G Macêdo; Jair P Cunha; Thyago H S Cardoso; Murilo V Silva; Fernanda M Santiago; João S Silva; Carlos P Pirovani; Deise A O Silva; José R Mineo; Tiago W P Mineo
Journal:  Parasit Vectors       Date:  2013-06-05       Impact factor: 3.876

Review 8.  Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii.

Authors:  Yanhua Wang; Hong Yin
Journal:  Parasit Vectors       Date:  2014-04-13       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.